MY120190A - Potentiation of the analgesic effect of buprenorphine - Google Patents

Potentiation of the analgesic effect of buprenorphine

Info

Publication number
MY120190A
MY120190A MYPI20005444A MY120190A MY 120190 A MY120190 A MY 120190A MY PI20005444 A MYPI20005444 A MY PI20005444A MY 120190 A MY120190 A MY 120190A
Authority
MY
Malaysia
Prior art keywords
buprenorphine
nalmefene
naltrexone
naloxone
amount
Prior art date
Application number
Inventor
Christopher Bourne Dr Chapleo
Nicolas Calvert Dr Varey
Keith Dr Mccormack
Original Assignee
Reckitt Benckiser Healthcare
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt Benckiser Healthcare filed Critical Reckitt Benckiser Healthcare
Publication of MY120190A publication Critical patent/MY120190A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

AN ANALGESIC COMPOSITION IN PARENTERAL UNIT DOSAGE FORM OR IN A UNIT DOSAGE FORM SUITABLE FOR DELIVERY VIA THE MUCOSA COMPRISING AN AMOUNT OF BUPRENORPHINE WHICH IS LESS THAN THE CLINICAL DOSE REQUIRED TO ACHIEVE PAIN RELIEF AND AN AMOUNT OF NALOXONE SUCH THAT THE RATIO BY WEIGHT OF BUPRENORPHINE TO NALOXONE IS IN THE RANGE OF FROM 12.5:1 TO 27.5:1, OR AN AMOUNT OF NALTREXONE OR NALMEFENE SUCH THAT THE RATIO BY WEIGHT OF BUPRENORPHINE TO NALTREXONE OR NALMEFENE IS IN THE RANGE OF FROM 12.5:1 TO 22.5:1, WHEREBY THE ANALGESIC ACTION OF THE BUPRENORPHINE IS POTENTIATED BY THE LOW DOSE OF NALOXONE, NALTREXONE OR NALMEFENE.
MYPI20005444 2000-01-14 2000-11-21 Potentiation of the analgesic effect of buprenorphine MY120190A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17620800P 2000-01-14 2000-01-14

Publications (1)

Publication Number Publication Date
MY120190A true MY120190A (en) 2005-09-30

Family

ID=47227334

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20005444 MY120190A (en) 2000-01-14 2000-11-21 Potentiation of the analgesic effect of buprenorphine

Country Status (1)

Country Link
MY (1) MY120190A (en)

Similar Documents

Publication Publication Date Title
WO2001035942A3 (en) Analgesic compositions containing buprenorphine
HK1139871A1 (en) Improvements in and relating to medicinal compositions
MX2009009132A (en) Improved medicinal compositions comprising buprenorphine and naltrexone.
IL185345A0 (en) Analgesic compositions comprising anti-epileptic compounds and methods of using same
MXPA02007690A (en) Controlled release compositions containing opioid agonist and antagonist.
NZ508526A (en) Opioid formulations for treating pain
MX2009009133A (en) Improved medicinal compositions comprising buprenorphine and naloxone.
ZA968808B (en) Production of analgesic synergy by co-administration of sub-analgesic doses of a mu opioid agoinst and a kappa-2 opioid agonist
UA93543C2 (en) Use of dosage form containing oxycodone and naloxone
ZA200606173B (en) Effervescent oral opiate dosage form
WO2001091736A3 (en) Combinations of an endothelin receptor antagonist and an antiepileptic compound having pain alleviating properties or analgesic
WO2001082914A3 (en) Topical anesthetic/opioid formulations and uses thereof
WO2000021515A3 (en) Intranasal codeine for the rapid suppression of cough and rapid relief of pain
WO2005041925A3 (en) Compositions and dosage forms for enhanced absorption
SI1041987T1 (en) Pharmaceutical oral dosage form comprising a combination of an opioid agonist and naltrexone
EP2255806A3 (en) Fentanyl composition for nasal administration
HUP0101268A2 (en) Pharmaceutical compositions for treating female sexual dysfunction
MX2009009134A (en) Improved medicinal compositions comprising buprenorphine and nalmefene.
WO2001001972A3 (en) SELECTIVE iGluR5 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF MIGRAINE
NZ590981A (en) Transdermal therapeutic system (TTS) for administration with a wafer
WO2001074365A3 (en) An efficacious dosage regimen of galantamine that reduces side effects
WO2000048446A3 (en) Use of antagonists of pg-e for the treatment of neuropathic pain
MY120190A (en) Potentiation of the analgesic effect of buprenorphine
WO2001085188A3 (en) Use of echinacea as a hematinic agent
CA2400578A1 (en) Controlled-release compositions containing opioid agonist and antagonist